Slideshow
Author(s):
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.
New Published Guideline Provides Recommendations for Primary Stroke Prevention Across Life Span
Episode 109: AB126, Exosomes, and Cerebroprotection for Stroke
Promising Outcomes for Spinal Stenosis and Spondylolisthesis: An Alternative to Spinal Fusion
Episode 105: Recapping Conversations in Neurology From 2023
Expanding the Boundaries of Neurosurgical Care: Recent Advances Give Patients New Hope
FDA Grants Breakthrough Therapy Designation to Edaravone Dexborneol Combination Therapy for Acute Ischemic Stroke